Article
Revealing a Mutant-Induced Receptor Allosteric Mechanism for the Thyroid Hormone Resistance
1 Oct 2019
Abstract excerpt
Resistance to thyroid hormone (RTH) is a clinical disorder without specific and effective therapeutic strategy, partly due to the lack of structural mechanisms for the defective ligand binding by mutated thyroid hormone receptors (THRs). We herein uncovered the prescription drug roxadustat as a novel THRβ-selective ligand with therapeutic potentials in treating RTH, thereby providing a small molecule tool...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
